You are here
Primary metastatic prostate cancer
Under-representation of racial minorities in prostate cancer studies submitted to the US Food and Drug Administration to support potential marketing approval, 1993-2013
Wissing M.D. Kluetz P.G. Ning Y.-M. Bull J. Merenda C. Murgo A.J. Pazdur R.Cancer 2014 Oct 1;120(19):3025-32.
Cytoreductive radical prostatectomy in patients with prostate cancer and low volume skeletal metastases: Results of a feasibility and case-control study
J Urol. 2015 Mar;193(3):832-8Abstract PURPOSE: Androgen deprivation represents the standard treatment for prostate cancer with osseous metastases. We explored the role of cytoreductive...
Long-term Efficacy and Safety of Enzalutamide Monotherapy in Hormone-naïve Prostate Cancer: 1- and 2-Year Open-label Follow-up Results
Bertrand Tombal, Michael Borre, Per Rathenborg, Patrick Werbrouck, Hendrik Van Poppel, Axel Heidenreich, Peter Iversen, Johan Braeckman, Jiri Heracek, Edwina Baskin-Bey, Taoufik Ouatas, Frank Perabo, De Phung, Benoit Baron, Mohammad Hirmand, Matthew R. Smith
K.A. Ahmed, B.M. Barney, B.J. Davis, S.S. Park, E.D. Kwon, K.R. Olivier.Frontiers in Oncology (2013), 2 JAN Article Number: Article 215. Date of Publication: 2013
In the past, radiotherapy for bone metastases in CRPC was only indicated when pain was prevalent. With newer...
Efficacy, patient-reported outcomes (PROs), and tolerability of the changing therapeutic landscape in patients with metastatic prostate cancer (MPC): A systematic literature review
B.S. Seal, C.V. Asche, K. Puto, and P.D. Allen.Value in Health, Volume 16, Issue 5, Pages 872–890, July–August 2013
This review give a timely overview over the rapidly changing landscape in mCRPC treatment. However, due to the...
Incidence and risk of denosumab-related hypocalcemia in cancer patients: A systematic review and pooled analysis of randomized controlled studies
W.-X. Qi, F. Lin, A.-N. He, L.-N. Tang, Z. Shen, Y. Yao.Current Medical Research and Opinion, Volume 29, Issue 9, Pages 1067-1073, September 2013.
This analysis of several randomized trials confirms the increased risk of hypocalcemia in patients treated with Denosumab. Calcium...
The use of the EVITA algorithm for clinical assessment of novel agents used in prostate cancer, metastatic melanoma, and systemic lupus erythematosus.
Szucs T.D. Puri D. Blank P.R.Eur J Clin Pharmacol. 2014 Aug;70(8):983-90. Epub 2014 May 27.
By Liu, Z.-Q., Chu, L., Fang, J.-M., Zhang, X., Zhao, H.-X., Chen, Y.-J., Xu and Q.Asian Journal of Andrology, Volume 16, Issue 3, 1 May 2014, Pages 467-471
Continued Benefit to Androgen Deprivation Therapy for Prostate Cancer Patients Treated With Dose-Escalated Radiation Therapy Across Multiple Definitions of High-Risk Disease
Matthew H. Stenmark M.D., Kevin Blas B.S., Schuyler Halverson B.S., Howard M. Sandler M.D., Felix Y. Feng M.D., Daniel A. Hamstra M.D., Ph.D.
International Journal of Radiation Oncology*Biology*Physics, 4, 81, pages e335 - e344